NAD+ Capsules: Clinical Evidence & Personalization Factors

Last reviewed: May 30, 2026

Last updated: May 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

NAD+ capsules are oral supplements formulated to increase nicotinamide adenine dinucleotide levels, a coenzyme essential for ATP production and cellular energy. Clinical research suggests NAD+ precursors like NMN and NR may support mitochondrial function and metabolic health in specific populations.

Choosing the right NAD+ strategy requires understanding your baseline NAD+ status, metabolic rate, and individual factors that influence absorption and cellular uptake. PlexusDx's precision-wellness approach emphasizes biomarker context and genetic predispositions that may inform whether oral capsules, injectable forms, or combination approaches deserve consideration with your provider.

Understanding NAD+ Physiology and Capsule Formulations

NAD+ naturally declines with age—roughly 50% reduction by age 60 according to published research. Oral capsule formulations typically contain NAD+ precursors (NMN, NR, or nicotinamide) rather than direct NAD+ because the molecule has poor oral bioavailability. These precursors enter cells and are converted back to NAD+ via salvage pathways.

Common capsule ingredients include nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR). NMN may penetrate cell membranes more efficiently than NR in some models, but human absorption data remains limited. Dosing typically ranges 250–1000 mg daily, though optimal doses for clinical outcomes remain under investigation.

Comparing Capsules, Injections, and Sublingual NAD+ Delivery

NAD+ supplementation is available in multiple forms, each with distinct bioavailability profiles and practical considerations. Capsules offer convenience and precise dosing; injectable NAD+ may bypass GI absorption variability; sublingual or IV formulations claim faster systemic availability. Provider guidance on which format matches your health context is essential before selection.

Delivery Method	Key Characteristics
Oral Capsules (NMN/NR)	Convenient daily dosing, variable GI absorption, lower cost, 250–1000 mg typical range
Injectable NAD+	Direct systemic delivery, bypasses GI tract, requires clinical administration, higher per-dose cost
Sublingual/Lozenges	Bypasses stomach acid, modest absorption data in humans, intermediate convenience
Intravenous NAD+	Maximum bioavailability, requires IV access, short half-life (30–60 minutes), clinical setting required

Clinical Evidence for NAD+ Capsules in Metabolic Health

Human trials on oral NAD+ precursors show mixed results. A 2021 study in *Science* reported NMN improved insulin sensitivity and aerobic capacity in prediabetic adults, while other trials found modest or null effects on energy or cognitive function. Effect sizes often correlate with baseline NAD+ status and mitochondrial reserve.

Age, physical activity level, and existing metabolic conditions influence NAD+ response. Sedentary individuals with metabolic syndrome may experience larger benefit signals than healthy young adults. Baseline bloodwork assessing NAD+ levels, insulin sensitivity, and mitochondrial markers can help contextualize whether capsule supplementation aligns with clinical goals.

Biomarker Context and Provider-Guided Selection Criteria

Before starting NAD+ capsules, qualified providers often assess baseline NAD+ levels, sirtuin activity, mitochondrial function markers, and metabolic parameters like fasting glucose and insulin sensitivity. These biomarkers provide clinical context for whether supplementation is warranted and help predict response likelihood. Individual genetic factors also influence NAD+ synthesis and salvage pathway efficiency.

A comprehensive pre-supplementation evaluation should include liver and kidney function tests, medication interactions, and assessment of underlying metabolic or mitochondrial conditions. Genetic variations in NAMPT (NAD+ biosynthesis enzyme) and PARPs (NAD+ consumers) may influence individual sensitivity to NAD+ supplementation. Provider guidance tailored to your biomarker profile ensures safer, more personalized decision-making.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test reveals predispositions in metabolic and cellular energy pathways, including variants in genes regulating mitochondrial function and NAD+ metabolism. While this test is specifically designed for peptide pathway optimization, understanding your genetic predispositions to mitochondrial efficiency may help provide context for why NAD+ supplementation might support cellular resilience in your case. This information should be interpreted with a qualified healthcare provider.

The Precision Peptide Genetic Test identifies key metabolic variants that influence energy homeostasis and cellular repair pathways. Genetic predispositions in mitochondrial and sirtuin-related pathways may indicate whether your body's natural NAD+ salvage mechanisms are efficient or require exogenous support. Genetic data does not predict exact NAD+ supplement response, but can support a more informed conversation with your provider about whether capsules align with your biochemical profile.

If you're considering NAD+ capsules as part of a broader metabolic wellness strategy, PlexusDx genetic insights combined with baseline biomarker testing can help your provider build a personalized supplementation plan. Integrating genetic context, mitochondrial health markers, and clinical evidence creates a more precise foundation for whether oral NAD+ precursors, injectable formats, or alternative approaches best fit your individual physiology and goals.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $179-$229/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Do NAD+ capsules actually raise NAD+ levels in the body?

Oral NAD+ precursors like NMN and NR may increase intracellular NAD+ in some tissues, but absorption varies widely due to metabolism and individual factors. Bloodwork can confirm whether supplementation elevates circulating levels in your specific case. Provider monitoring is recommended.

How long does it take to see results from NAD+ capsules?

Clinical studies typically assess NAD+ supplementation over 4–12 weeks. Energy, cognitive, or metabolic improvements may emerge within 4–8 weeks in responsive individuals, but baseline NAD+ status and lifestyle factors significantly influence response timeline. Patience and provider assessment are warranted.

What's the difference between NAD+ capsules and NAD+ injections?

Capsules rely on GI absorption and require conversion from precursors; injections bypass the stomach and deliver NAD+ or precursors directly. Injections may achieve higher systemic levels but require clinical administration. Choice depends on bioavailability needs, cost, and clinical goals.

Are NAD+ capsules safe for long-term use?

Short-term safety data (up to 12 weeks) is generally favorable, but long-term safety in humans remains understudied. Liver and kidney function should be monitored, especially at higher doses or in those with pre-existing metabolic conditions. Provider oversight is essential for ongoing supplementation.

Can genetic testing predict whether NAD+ capsules will work for me?

Genetic predispositions in NAD+ synthesis and mitochondrial pathways may provide context for individual sensitivity, but genetics alone cannot predict exact supplement response.

NAD+ Capsules: Biomarker Context and Provider-Guided Selection